Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2003
06/12/2003WO2003048783A2 Monocyte adhesion
06/12/2003WO2003048782A1 Method for diagnosing sepsis by determining soluble cytokeratin fragments
06/12/2003WO2003048781A1 Uses of the glycine-n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048780A2 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048779A1 Method for detecting allergies and use of an antibody to detect allergies
06/12/2003WO2003048778A1 Method for diagnosis of sepsis by determination of s100b
06/12/2003WO2003048777A1 Method for diagnosis of sepsis by determination of ca 19-9
06/12/2003WO2003048776A1 Method for diagnosis of sepsis by determination of ca 125
06/12/2003WO2003048775A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003WO2003048774A1 Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors
06/12/2003WO2003048773A2 Methods for monitoring amyotrophic lateral sclerosis
06/12/2003WO2003048772A2 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
06/12/2003WO2003048771A2 Device for analysing analyte compounds and use hereof
06/12/2003WO2003048770A2 Method for performing in vitro diagnosis using gene regulation mechanisms and corresponding diagnosis kit
06/12/2003WO2003048768A2 Protein arrays for allelic variants and uses thereof
06/12/2003WO2003048766A2 Colorimetric artemisinin and artemisinin derivatives assay and assay kit
06/12/2003WO2003048765A1 Breath test
06/12/2003WO2003048764A1 Composition for blood serum or plasma separation and vessel for blood examination containing the same
06/12/2003WO2003048763A1 Method for determining residual fuel and insolubles contamination in used marine engine lubricants using uv-visible spectroscopy and chemometrics
06/12/2003WO2003048762A2 System and method for health monitoring of aquatic species
06/12/2003WO2003048761A1 Method and device for measuring animal meat tenderness or fish freshness
06/12/2003WO2003048760A2 Method and apparatus for detecting the presence of ammonium nitrate and a sugar or a hydrocarbon
06/12/2003WO2003048759A1 Method for analyzing an unknown material as a blend of known materials calculated so as to match certain analytical data and predicting properties of the unknown based on the calculated blend
06/12/2003WO2003048756A1 Biosensor
06/12/2003WO2003048753A2 A method and device for measuring atomic hydrogen flow density
06/12/2003WO2003048738A1 Method for measuring gas generated by material
06/12/2003WO2003048736A2 Microfluidic device and surface decoration process for solid phase affinity binding assays
06/12/2003WO2003048735A2 Processes for the measurement of the potency of glatiramer acetate
06/12/2003WO2003048734A2 Detection of matrix metalloproteinase rna in plasma and serum
06/12/2003WO2003048731A2 Antibody categorization based on binding characteristics
06/12/2003WO2003048730A2 Identification of high affinity molecules by limited dilution screening
06/12/2003WO2003048729A2 Discovery of therapeutic products
06/12/2003WO2003048723A2 Label-free detection of nucleic acids via surface plasmon resonance
06/12/2003WO2003048720A2 Computer system and method for calculating adme properties
06/12/2003WO2003048719A2 Device for detecting oil penetration into the measuring chamber of a gas sensor connected to a transformer chamber by means of a membrane, and heating device for transformer oil
06/12/2003WO2003048692A1 Gas meter with improved calorific measurement
06/12/2003WO2003048682A1 Apparatus and method for detecting twist in articles
06/12/2003WO2003048396A1 A method for identifying markers
06/12/2003WO2003048387A2 Labelled nucleotides
06/12/2003WO2003048384A2 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048382A1 Sensitive detection of urea and related compounds in water
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048372A2 Methods and apparatus for complex genetics classification based on correspondence analysis and linear/quadratic analysis
06/12/2003WO2003048363A1 Complex of assigned molecule with c-end labeled protein, assigned molecule complex and methods of analyzing interaction between proteins using these complexes
06/12/2003WO2003048359A1 Markers for sugar/lipid metabolic disorders and utilization thereof
06/12/2003WO2003048356A1 Screening methods employing fish model assessment of vision
06/12/2003WO2003048355A1 Method and apparatus for high frequency interfacing to biochemical membranes
06/12/2003WO2003048352A2 Histone h3 methyltransferase polypeptide
06/12/2003WO2003048345A1 Phenotypic screen of chimeric proteins
06/12/2003WO2003048340A2 Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof
06/12/2003WO2003048337A2 Antibody to latent membrane proteins and uses thereof
06/12/2003WO2003048334A2 Immunocytokines with modulated selectivity
06/12/2003WO2003048333A2 Endorepellin compositions and methods for inhibiting angiogenesis
06/12/2003WO2003048314A2 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips
06/12/2003WO2003048302A2 Identifying anti-tumor targets or agents by lipid raft immunization and proteomics
06/12/2003WO2003048301A2 Anti-hla-dr antibodies and the methods of using thereof
06/12/2003WO2003048300A2 Methods of identifying cellular target molecules
06/12/2003WO2003048295A1 Microfluidic device and methods of using same
06/12/2003WO2003048203A1 Stereostructure of dna replication regulatory protein and use thereof
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048193A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
06/12/2003WO2003048191A2 Process for the selective alkylation of -sh groups in proteins and peptides for the study of complex protein mixtures
06/12/2003WO2003048177A1 Management sample of d-chiro-inositol
06/12/2003WO2003047746A1 Oxidation reactor, method for producing (meth)acrylic acid or the like, and method for analyzing easily polymerizable compound
06/12/2003WO2003047739A2 Method for producing chemical libraries enhanced with biologically active molecules
06/12/2003WO2003047738A2 Liquid interface configurations for automated patch clamp recording
06/12/2003WO2003047623A1 Treatment of prostate cancer by inhibitors of ncam2
06/12/2003WO2003047615A1 Dexar agonists and antagonists for use in the treatment of metabolic disorders
06/12/2003WO2003047614A1 Agonist and antagonists of redax for the treatment of metabolic disorders
06/12/2003WO2003047613A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer
06/12/2003WO2003047611A2 Ptp10d, tec and edtp involved in triglycerid-metabolism
06/12/2003WO2003047606A2 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
06/12/2003WO2003047514A2 Reducing myelin-mediated inhibition of axon regeneration
06/12/2003WO2003047509A2 Enzyme activity profiles
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003WO2003047421A2 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003WO2003047420A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
06/12/2003WO2003047331A2 Methods and apparatus for cell based screening
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2003023361A3 Distinguishing agonists, antagonists, and inverse agonists using pwr
06/12/2003WO2003020734A3 Labeled nucleoside polyphosphates
06/12/2003WO2003018752A3 An organotypic intestinal culture and methods of use thereof
06/12/2003WO2003016860A3 Systems and methods for screening pharmaceutical chemicals
06/12/2003WO2002103031A3 Methods for detecting and treating the early onset of aging-related conditions
06/12/2003WO2002093318A3 Systems and methods for monitoring behavior informatics
06/12/2003WO2002090989A3 Method for detecting blood cell antigens and the antibodies in response to the same
06/12/2003WO2002090987A3 Universal fluorescent sensors
06/12/2003WO2002084266A3 Biological measurement system
06/12/2003WO2002057465A3 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
06/12/2003WO2002054044A3 Focused acoustic ejection cell sorting system and method
06/12/2003WO2002021136A3 Method for quantitatively determining the available binding capacity in an aqueous protein solution
06/12/2003WO2002021102A3 Particle or cell analyzer and method
06/12/2003WO2002018544A3 Method and reagents for treatment of skin disorders by modulating the notch pathway
06/12/2003WO2002008748A9 Ion channel assay methods
06/12/2003WO2001088188A3 Method for examining ischemic conditions
06/12/2003WO2001088126A8 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
06/12/2003WO2001085096A9 Mast cell regulation
1 ... 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 ... 3937